<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-8-43</article-id><article-id pub-id-type="pmid">18430230</article-id><article-id pub-id-type="doi">10.1186/1471-213X-8-43</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Buttler</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>buttler.kerstin@med.uni-goettingen.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Ezaki</surname><given-names>Taichi</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>ezakit@research.twmu.ac.jp</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Wilting</surname><given-names>J&#x000f6;rg</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>joerg.wilting@med.uni-goettingen.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Centre of Anatomy, Department of Anatomy and Cell Biology, University Medicine Goettingen, Goettingen, Germany</aff><aff id="I2"><label>2</label>Department of Anatomy and Developmental Biology, Tokyo Women's Medical University, Tokyo, Japan</aff><aff id="I3"><label>3</label>University Medicine Goettingen, Centre of Anatomy, Department of Anatomy and Cell Biology, Kreuzbergring 36, 37075 Goettingen, Germany</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2008</year></pub-date><volume>8</volume><fpage>43</fpage><lpage>43</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/8/43"/><history><date date-type="received"><day>16</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Buttler et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Buttler et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Buttler Kerstin buttler.kerstin@med.uni-goettingen.de </dc:author><dc:title> Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 8(1): 43-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2008)8:1&#x0003c;43&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The data on the embryonic origin of lymphatic endothelial cells (LECs) from either deep embryonic veins or mesenchymal (or circulating) lymphangioblasts presently available remain inconsistent. In various vertebrates, markers for LECs are first expressed in specific segments of embryonic veins arguing for a venous origin of lymph vessels. Very recently, studies on the mouse have strongly supported this view. However, in the chick, we have observed a dual origin of LECs from veins and from mesodermal lymphangioblasts. Additionally, in murine embryos we have detected mesenchymal cells that co-express LEC markers and the pan-leukocyte marker CD45. Here, we have characterized the mesoderm of murine embryos with LEC markers Prox1, Lyve-1 and LA102 in combination with macrophage markers CD11b and F4/80.</p></sec><sec><title>Results</title><p>We observed cells co-expressing both types of markers (e.g. Prox1 &#x02013; Lyve-1 &#x02013; F4/80 triple-positive) located in the mesoderm, immediately adjacent to, and within lymph vessels. Our proliferation studies with Ki-67 antibodies showed high proliferative capacities of both the Lyve-1-positive LECs of lymph sacs/lymphatic sprouts and the Lyve-1-positive mesenchymal cells.</p></sec><sec><title>Conclusion</title><p>Our data argue for a dual origin of LECs in the mouse, although the primary source of embryonic LECs may reside in specific embryonic veins and mesenchymal lymphangioblasts integrated secondarily into lymph vessels. The impact of a dual source of LECs for ontogenetic, phylogenetic and pathological lymphangiogenesis is discussed.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The important physiological and pathophysiological roles of the lymphatic vascular system for fluid homeostasis, immune surveillance, inflammation and tumour metastasis justify intensive studies of this hardly visible portion of the vascular system [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Insufficient development of lymph vessels becomes immediately apparent as lymph oedema, which mostly affects the legs and the genital region of patients. Primary lymph oedema (Nonne-Milroy Syndrome) is caused by mutations in the tyrosine kinase domain of the Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) gene on 5q35.3 [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Kaposi's sarcoma probably represents a form of lymphatic endothelial cell (LEC) hyperplasia [<xref ref-type="bibr" rid="B5">5</xref>], but circulating precursor cells may also be involved [<xref ref-type="bibr" rid="B6">6</xref>]. However, it is still not clear whether lymphangioma, which is found in 1.2 &#x02013; 2.8&#x02030; of infants [<xref ref-type="bibr" rid="B7">7</xref>], is due to hyperplasia of LECs or structural malformations of lymph vessels [<xref ref-type="bibr" rid="B8">8</xref>]. These uncertainties with respect to the pathobiology of lymph vessels are based on the fact that the mechanisms of normal embryonic lymphangiogenesis and the origin of LECs are not sufficiently well understood.</p><p>Following the identification of specific markers for LECs, our knowledge of the structure and function of lymph vessels and the molecular equipment of LECs has increased enormously in recent years [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Nevertheless, the embryonic origin of the lymphatic vascular system has been discussed controversially for more than a hundred years, and is still open for discussion. The two main theories are the 'centrifugal' and 'centripetal' theory. The first was set up by Sabin [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>] and Lewis [<xref ref-type="bibr" rid="B13">13</xref>] and proposes a venous origin of the lymph sacs (which are the first clear morphological signs of lymph vessel development), with subsequent sprouting of lymph vessels into all tissues and organs of the body. The second was set up by Huntington and McClure [<xref ref-type="bibr" rid="B14">14</xref>] and proposes formation of lymphatic vessels from mesenchymal 'lymphatic clefts', which, nowadays, are called lymphangioblasts. Several recent studies clearly show development of LECs from the venous system in the murine embryo [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. However, an intermediate position favouring a dual origin from embryonic veins and mesenchymal lymphangioblasts was defined by studies on avian embryos and Xenopus tadpoles [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Migration of mesenchymal lymphangioblasts, which are originally located in the venous system and delaminate from the endothelium, has been observed in fish [<xref ref-type="bibr" rid="B21">21</xref>]. Additionally, our previous studies have demonstrated the existence of mesenchymal cells which co-express leukocyte (CD45) and lymphendothelial markers (Prox1, Lyve-1) in mouse embryos [<xref ref-type="bibr" rid="B19">19</xref>]. Recent studies on pathological lymphangiogenesis in adult mice have provided evidence of a role of circulating endothelial progenitor cells (CEPCs) and macrophages (CD11b and F4/80 positive) in this process [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Evidence of CEPCs in humans has been provided in studies on post-transplantation Kaposi's sarcoma [<xref ref-type="bibr" rid="B6">6</xref>] and kidney graft rejection [<xref ref-type="bibr" rid="B25">25</xref>].</p><p>The detection of cells, which co-express macrophage and lymphendothelial markers in the adult mouse, prompted us to investigate such cells in the murine embryo. We used antibodies against CD31/PECAM-1, a pan-endothelial marker, in combination with LEC-specific markers: Prox1, a homeobox transcription factor, Lyve-1, a hyaluronan receptor, and LA102, a recently defined new epitope on LECs [<xref ref-type="bibr" rid="B26">26</xref>]. Double and triple staining were then performed with macrophage markers CD11b and F4/80. These studies, in combination with the proliferation marker Ki-67, provide evidence for the existence of actively dividing mesenchymal cells, which co-express macrophage and lymphendothelial markers in early mouse embryos. The mesenchymal localization of the cells in murine embryos suggests an additional source of LECs, which may integrate into lymph vessels that have primarily originated and sprouted from embryonic veins. The existence of highly mobile (macrophage-like) cells with LEC characteristics seems to be relevant for pathological lymphangiogenesis and inflammation-associated organ rejection [reviews see: [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]].</p></sec><sec><title>Results</title><sec><title>Cells with pan-endothelial, lymphendothelial and macrophage characteristics</title><p>During early stages of lymphendothelial commitment, the LEC markers Prox1 and Lyve-1 are expressed by cells of the cardinal veins of the mouse on approximately embryonic day (ED) 9.5 [<xref ref-type="bibr" rid="B17">17</xref>]. These cells are also positive for CD31/PECAM-1, a pan-endothelial marker, which is strongly expressed in blood endothelial cells (BECs) and more weakly in LECs [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. The precursor cells give rise to lymph sacs which, in the jugular region, are located in the angle between anterior and posterior cardinal veins [<xref ref-type="bibr" rid="B15">15</xref>], as can be demonstrated by staining with anti-Lyve-1 antibodies (Fig. <xref ref-type="fig" rid="F1">1</xref>). However, the lymph sacs are not the only structures which are Lyve-1-positive. There are large numbers of scattered cells, preferentially located in the loose mesenchyme (Fig. <xref ref-type="fig" rid="F1">1A</xref>). On ED 13.5 the lymphatic vascular system of murine embryos is made up of a deep and a superficial part. The deep part consists of the lymph sacs located alongside the jugular segment of the cardinal veins (Fig. <xref ref-type="fig" rid="F1">1A,B</xref>). The superficial lymphatics are located in the dermis. They are connected to the deep system by lymphatic vessels, which are located in the mesenchyme underneath the skeletal elements of the shoulder girdle. Additionally, there are large numbers of scattered Lyve-1-positive cells in the loose mesenchyme of the dermis, the primitive meninges and the parapharyngeal region. The neural tube, skeletal elements and muscles do not contain such cells.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Jugular lymph sacs of murine embryos</bold>. Lyve-1 staining of paraffin sections (A, B) and double staining of cryo-sections (C-F) of ED 13.5 (A-C, E, F) and 12.5 (D) mice. A, B) The jugular lymph sacs (jls) are Lyve-1<sup>+ </sup>and located dorso-laterally of the cardinal vein (v). Many scattered Lyve-1<sup>+ </sup>cells are located superficially in the developing dermis (arrows). nt, neural tube. B) Higher magnification of A showing JLS in close proximity to the cardinal vein. C) Lymph sacs express Prox1 (red) and Lyve-1 (green). D) Prox1 (red) and LA102 (green). E) Lyve-1 (red) and LA102 (green). Note double positive LECs, although staining of lymph sac LECs with LA102 is heterogeneous. F) Lymphatic vessel (arrow) in the dermis is double positive for Lyve-1 and LA102 (yellow).</p></caption><graphic xlink:href="1471-213X-8-43-1"/></fig><p>Our double staining protocol confirms that LECs of the jugular lymph sacs are Prox1<sup>+ </sup>and Lyve-1<sup>+ </sup>(Fig. <xref ref-type="fig" rid="F1">1C</xref>). The new lymphendothelial marker LA102, a monoclonal antibody recognizing a 25 &#x02013; 27 kDa protein, specifically reacts with lymphatic vessels of the adult mouse, except for those of the thoracic duct and the marginal sinus of lymph nodes, but not with any blood vessels [<xref ref-type="bibr" rid="B26">26</xref>]. We investigated the expression of LA102 during early embryonic lymphangiogenesis of ED 11.5 &#x02013; 13.5 mice and performed double staining with either Prox1 or Lyve-1. On ED 12.5 and ED 13.5, we observed that LECs in the jugular lymph sacs were double positive for Prox1 and LA102 (Fig. <xref ref-type="fig" rid="F1">1D</xref>) as well as Lyve-1 and LA102 (Fig. <xref ref-type="fig" rid="F1">1E</xref>). The same results hold true for the superficial lymphatics of the dermis (Fig. <xref ref-type="fig" rid="F1">1F</xref>). However, in the mediastinal region, we found some lymphatic vessels which expressed only Lyve-1, while others demonstrated Lyve-1 and LA102 co-expression (data not shown).</p><p>The data show that all three markers, Prox1, Lyve-1 and LA102 are expressed by LECs of lymph sacs and lymph vessels, although each is also expressed by some non-endothelial cell types. In order to characterize the scattered mesenchymal Lyve-1<sup>+ </sup>cells shown in Figure <xref ref-type="fig" rid="F1">1A</xref>, we used double and triple staining with lymph/endothelial and macrophage markers. In our previous studies, we showed that some mesenchymal Lyve-1<sup>+ </sup>cells co-expressed Prox1 [<xref ref-type="bibr" rid="B19">19</xref>]. Here, we detected a small number of Prox1<sup>+</sup>/CD31<sup>+ </sup>mesenchymal cells in the dermatomes on ED 10 (Fig. <xref ref-type="fig" rid="F2">2A,B</xref>). CD31 expression in these cells, which we regard as lymphangioblasts, is lower than in BECs. Co-staining with LA102 and Prox1 antibodies revealed that some scattered cells in the mesenchyme are double positive (Fig. <xref ref-type="fig" rid="F2">2C</xref>). On ED 12.5 we observed single cells in the mesenchyme surrounding the neural tube which co-expressed Lyve-1 and LA102, but there were also cells only positive for LA102 (Fig. <xref ref-type="fig" rid="F2">2D</xref>). It has been reported that CD11b<sup>+ </sup>macrophages may contribute to pathological lymphangiogenesis in the cornea of adult mice [<xref ref-type="bibr" rid="B22">22</xref>]. We detected a small number of Prox1<sup>+</sup>/CD11b<sup>+ </sup>cells in the mesenchyme of ED 12.5 mice (Fig. <xref ref-type="fig" rid="F2">2E</xref>). LECs of the jugular lymph sacs on ED 13.5 were CD11b-negative, but a few Lyve-1<sup>+</sup>/CD11b<sup>+ </sup>cells were located immediately adjacent to the lymph sacs (Fig. <xref ref-type="fig" rid="F2">2F</xref>), and appeared to be integrated into the superficial dermal lymph vessels (Fig. <xref ref-type="fig" rid="F2">2G</xref>).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Double staining of scattered mesodermal cells with pan-endothelial, lymphendothelial and macrophage markers of ED 10 (A, B), ED 12.5 (D, E) and ED 13.5 (C, F, G) mouse embryos</bold>. A) Two mesenchymal cells of the dermatome (arrows) which are located at a great distance from the cardinal vein (v) express CD31 (green) and Prox1 (red). nt, neural tube. B) Higher magnification of A). Note weak CD31 expression of Prox1<sup>+ </sup>mesenchymal cells (arrows) as compared to blood vessels (bv). C) Cells double positive for lymphendothelial markers LA102 (green) and Prox1 (red), and D) LA102 (green) and Lyve-1 (red). E) Cells double positive for macrophage marker CD11b (green) and lymphendothelial marker Prox1 (red). F) Some cells co-express (yellow) CD11b (green) and Lyve-1 (red) in the mesenchyme adjacent to the JLS, and G) in the dermis, where a cell positive for both markers (arrow) seems to be integrated into a lymph vessel (lv).</p></caption><graphic xlink:href="1471-213X-8-43-2"/></fig><p>We then used the macrophage marker F4/80 for further characterisation of mesenchymal Lyve-1<sup>+ </sup>cells. A large number of scattered cells of the dermatomes, mediastinum and pimitive meninges co-expressed Lyve-1 and F4/80 in ED 13.5 embryos and some cells expressed only Lyve-1 or F4/80 (Fig. <xref ref-type="fig" rid="F3">3</xref>). There was a distinct difference between the frequencies of CD11b<sup>+ </sup>and F4/80<sup>+ </sup>cells in the mesenchyme. Many more F4/80<sup>+ </sup>cells could be found, and many of these were Lyve-1<sup>+</sup>. We, therefore, extended our studies by applying three markers: Prox1, Lyve-1 and F4/80. We found cells in the developing lymph sacs positive for all three markers in ED 13.5 mice (Fig. <xref ref-type="fig" rid="F4">4A&#x02013;F</xref>). More peripherally, in developing lymph vessels, we also found a small number of cells positive for all three markers (Fig. <xref ref-type="fig" rid="F5">5A,B</xref>). In very rare cases, we could observe various marker combinations in adjacent cells of lymph vessels. Figure <xref ref-type="fig" rid="F5">5A</xref> shows such an example with 3 cells: one positive only for F4/80, one expressing F4/80 and Lyve-1, and a third positive for F4/80, Lyve-1 and Prox1. The fact that two LEC markers, Prox1 and Lyve-1, can be found in F4/80<sup>+ </sup>cells, which appear to be integrated into lymph vessels, is a strong indication for a mesenchymal source of LECs in murine embryos.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>F4/80 (green) and Lyve-1 (red) staining of ED 13.5 mice</bold>. Many of the cells in the dermis are double positive (yellow), but some only express F4/80 or Lyve-1.</p></caption><graphic xlink:href="1471-213X-8-43-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Double and triple staining of ED 11.5 (A) and ED 13.5 (B &#x02013; F) mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green)</bold>. A) Cell showing co-expression of Prox1 and F4/80 (arrow), whereas another cell is only F4/80 positive. B) Overview showing the jugular lymph sac (jls) and the cardinal vein (v). Prox1 and Lyve-1 are co-expressed in LECs of the jls. Arrow indicates integration of F4/80<sup>+ </sup>cell into the jls. C) Higher magnification of B) showing triple positive cells of the JLS. D) Prox1, E) Lyve-1, F) F4/80.</p></caption><graphic xlink:href="1471-213X-8-43-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Triple staining of ED 13.5 mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green)</bold>. A, B) Triple positive cell integrated in a lymphatic vessel (arrow in A and B). A) Cell showing co-expression of Lyve-1 and F4/80 (white arrowhead), whereas another cell is only F4/80 positive (open arrowhead).</p></caption><graphic xlink:href="1471-213X-8-43-5"/></fig></sec><sec><title>Proliferation studies</title><p>Ki-67 is a well-established proliferation marker and is increasingly expressed in the nucleus in all active phases of the cell cycle, but not in G<sub>0 </sub>phase [<xref ref-type="bibr" rid="B31">31</xref>]. To extend our studies on the source of LECs, we performed double staining with anti-Ki-67 and anti-Lyve-1 antibodies of ED 11.5 &#x02013; 13.5 mice. Nuclei were counter stained with 4',6-diamidino-2-phenylindol (DAPI). Double positive LECs could be detected in regions of active lymphangiogenesis: the early jugular veins, the jugular lymph sacs, which extended sprouts into dorso-lateral directions, the mediastinum and the dermis (Fig. <xref ref-type="fig" rid="F6">6</xref>). Mouse embryos on ED 11.5 exhibited very few cells in the cardinal veins positive for both markers, whereas LECs of the developing jugular lymph sacs as well as mesenchymal cells in the dermis co-expressed Ki-67 and Lyve-1 at high rates (Fig. <xref ref-type="fig" rid="F6">6A,B</xref>). The dermatomes of ED 12.5 and 13.5 mice displayed scattered Lyve-1<sup>+ </sup>cells, which also showed proliferating characteristics (55% and 33%, respectively; Fig. <xref ref-type="fig" rid="F7">7</xref>). However, the total number of Lyve-1<sup>+ </sup>cells in the dermatomes was low compared with the number of lymph sac ECs. In the jugular lymph sacs (Fig. <xref ref-type="fig" rid="F6">6C</xref>) and in sprouts derived from them (Fig. <xref ref-type="fig" rid="F6">6D</xref>) the Ki-67 labelling rate was 22 &#x02013; 30% (Fig. <xref ref-type="fig" rid="F7">7</xref>). The data show that a greater number of Lyve-1<sup>+ </sup>cells are present in the lymph sacs than in the dermatomes, but the latter proliferate at equal or, in ED 12.5 embryos, even higher rates.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Paraffin sections of mouse embryos stained with antibodies against Ki-67 (green) and Lyve-1 (red)</bold>. Counter staining was performed with DAPI (blue). A) On ED 11.5, there are proliferating LECs in the developing jugular lymph sacs (jls) (arrows), but no double positive cells in the cardinal vein (v). B) Two mesenchymal cells positive for the markers located in the dermatome (arrows). g, spinal ganglion. C) JLS of ED 12.5 mice with LECs (arrows) expressing Ki-67 and Lyve-1. D) Sprout from the JLS containing proliferating cells (arrows). Inset: Higher magnification showing Ki-67-positive (arrow) and negative (arrowhead) LECs.</p></caption><graphic xlink:href="1471-213X-8-43-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Proliferation studies of Lyve-1<sup>+ </sup>cells with Ki-67 antibodies in ED 12.5 and ED 13.5 mice</bold>. For each ED, at least 5 sections of at least 3 mice were evaluated. The total number of cells counted was: 197 in lymph sacs (LS) on ED 12.5; 406 in lymph sacs (LS) on ED 13.5; 45 in sprouts from lymph sacs (Sp) on ED 12.5; 75 in sprouts from lymph sacs (Sp) on ED 13.5; 43 in scattered cells in the dermatomes (D) on ED 12.5 and 40 in scattered cells in the dermatomes (D) on ED13.5. Mean and standard deviation are shown. The value for D 12.5 is significantly higher than all others.</p></caption><graphic xlink:href="1471-213X-8-43-7"/></fig></sec></sec><sec><title>Discussion</title><sec><title>Embryonic lymphangiogenesis</title><p>Our data show that there is a cell type in early mouse development, which combines lymphendothelial (Lyve-1<sup>+</sup>, Prox1<sup>+</sup>) and macrophage (F4/80<sup>+</sup>) characteristics. Also, there are cells that express Lyve-1 and F4/80, as well as cells that have only one of these markers. The triple-positive cells appear to be integrated into the lining of early lymph vessels, and, in sum, the data are in favour of an origin of LECs from mesenchymal, macrophage-like cells. Although these cells may contribute only to the minor part of the lymphovascular system, their existence and possible contribution to pathological lymphangiogenesis should not be neglected.</p><p>Recent data by Srinivasan et al. [<xref ref-type="bibr" rid="B15">15</xref>] have provided clear evidence that the major part of the lymphovascular system of mice is of venous origin. The jugular segment of the cardinal veins is the source of the jugular lymph sacs, which then grow into peripheral parts of the body. Prox1-expressing venous ECs are the source of the jugular lymph sacs in the anterior region of the embryo. The posterior cardinal veins give rise to the posterior lymph sacs, which are the source of the lymphatics in the mesenteries and the posterior organs. The earliest Prox1-positive ECs are located in the jugular segment of the cardinal veins of ED 9.75 mice. A third place of origin of lymphatics is the orbital region [<xref ref-type="bibr" rid="B15">15</xref>]. Loss of Prox1 expression abolishes development of lymphatics [<xref ref-type="bibr" rid="B17">17</xref>]. Regular development of veins is another prerequisite for the generation of LECs. The absence of Coup-TFII, an orphan nuclear receptor transcription factor, causes embryonic death around ED 10, abnormal expression of arterial marker genes in the veins, and loss of jugular lymph sacs [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B36">36</xref>]. A contribution of hematopoietic cells to the lymphatics does not seem to exist. <italic>Runx1</italic>-null mice, which do not develop definitive hematopoietic cell [<xref ref-type="bibr" rid="B37">37</xref>], have normal jugular lymph sacs, and descendents of hematopoietic stem cells are not detectable in the mouse carrying a reporter gene under the control of the <italic>Runx1 </italic>promoter [<xref ref-type="bibr" rid="B15">15</xref>]. In all, these data show that the venous system is the main source of the embryonic lymphovascular system in mice.</p><p>Nevertheless, even the highly detailed studies on the venous origin of embryonic LECs cannot rule out the possibility of a minor contribution of mesenchymal cells to the lymphatics [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. In both of the studies cited, scattered Prox1-positive cells were observed along the anteroposterior axis of the body wall of early embryos &#x02013; at great distances from the developing lymph sacs. In the transgenic mice studied by Srinivasan et al. [<xref ref-type="bibr" rid="B15">15</xref>] some cells were detected, which did not fit into the anticipated pattern of the venous origin of LECs. Thus, there are some observations that argue for an additional source of LECs. The number of LECs derived from macrophage-like, mesenchymal precursors may be low, but that does not necessarily rule out functional importance. This is supported by studies on <italic>Syk </italic>and <italic>Slp-76 </italic>knockout mice. These adapter proteins mediate outside-in integrin signalling [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. Mouse embryos lacking Syk and Slp-76 functions develop abnormal blood-lymph-endothelial connections, and Slp-76 deficient cells confer this phenotype on chimeric embryos [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. <italic>Syk </italic>and <italic>Slp-76 </italic>are expressed in hematopoietic cells, but not in ECs. The incorporation of defective cells into abnormally fused lymph vessels and the rescue of the phenotype by GFPSlp-67-expressing circulating cells indicate a hematopoietic origin of LECs [<xref ref-type="bibr" rid="B40">40</xref>]. Normal <italic>Syk </italic>and <italic>Slp-76 </italic>functions may be required in early stages of development, when hemangioblasts divide into hematopoietic and endothelial lineages. <italic>Syk </italic>and <italic>Slp-76 </italic>are expressed by platelets and eosinophils, but not macrophages or dendritic cells [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>Incorporation of macrophages into lymph vessels has been indicated by studies on pathological lymphangiogenesis [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Our studies strongly suggest that similar mechanisms are found in embryonic lymphangiogenesis. In the adult, macrophages originate from circulating monocytes, but, in the embryo, their early development in the mesoderm is independent of the hematopoietic system. They can be isolated from the epiblast before gastrulation. So, they are present before the development of hematopoietic cells in blood islands [<xref ref-type="bibr" rid="B42">42</xref>]. After gastrulation, macrophages are found in all embryonic compartments, which is also evident in the studies presented here. Mesenchymal macrophages can give rise to stationary cells, which is best documented in the central nervous system (CNS) where they form the microglia [<xref ref-type="bibr" rid="B43">43</xref>], which has self-renewal potential. Our studies provide initial evidence for the incorporation of macrophage-like cells into the lining of lymph vessels during normal development.</p><p>There are large numbers of Lyve-1<sup>+ </sup>single cells in the mesenchyme of murine embryos, which are highly proliferative and obviously represent a heterogeneous cell population. Many of the cells express the pan-leukocyte marker CD45 [<xref ref-type="bibr" rid="B19">19</xref>]. Here, we show that some of the cells co-express other LEC markers such as Prox1 and LA102. Co-localization of Prox1 and CD31/PECAM-1 in scattered cells in the dermatomes of ED 10 mouse embryos is a strong indicator of a lymphangioblastic cell population. Prox1 is the most reliable marker that distinguishes between LECs and BECs in healthy and diseased tissues [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>], and CD31 is a highly reliable pan-endothelial marker. In birds, similar cells are present, and grafting of quail dermatomes into chick embryos has demonstrated the lymphangiogenic potential of this tissue [<xref ref-type="bibr" rid="B20">20</xref>]. Many of the Lyve-1<sup>+ </sup>single cells in the mesenchyme express F4/80, but only some are CD11b<sup>+</sup>. The F4/80 antibody recognises an extra-cellular membrane molecule, highly restricted to mature macrophage subpopulations. The antigen is not present on granulocytes, lymphocytes, mast cells, platelets, endothelial cells and blood monocytes [<xref ref-type="bibr" rid="B44">44</xref>]. CD11b is found on 'classical' macrophages such as alveolar and peritoneal macrophages, but not on dendritic cells [<xref ref-type="bibr" rid="B45">45</xref>]. We detected a small number of Prox1-Lyve-1-F4/80 triple-positive cells, which were obviously integrated into the lining of lymph vessels. Although this is a rare event, it demonstrates heterogeneity of LECs, probably due to heterogeneity of lymphangiogenic mechanisms, which may be relevant not only during embryonic lymphangiogenesis, but also in phylogeny and during pathological lymphangiogenesis.</p></sec><sec><title>Phylogenetic lymphangiogenesis</title><p>Development of LECs from macrophage-like progenitors might reflect an ancestral mechanism. This assumption is based on the observation that insects, which do not possess ECs [<xref ref-type="bibr" rid="B46">46</xref>], have macrophages that express ancestors of typical angiogenesis-associated molecules of vertebrates [<xref ref-type="bibr" rid="B47">47</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. The tubular heart (also called dorsal vessel) of insects is lined by contractile muscle cells, but not ECs [<xref ref-type="bibr" rid="B46">46</xref>]. In <italic>Drosophila </italic>supply with oxygen is accomplished by a tracheal system. Red blood cells are not present and the so-called hemolymphatic system fulfils functions of a typical lymphatic system. It has, therefore, been speculated that the lymphovascular system evolved before the blood vascular system, although during ontogeny the latter develops first [<xref ref-type="bibr" rid="B50">50</xref>]. Three types of immune cells are found in <italic>Drosophila</italic>: plasmatocytes, crystal cells and lamellocytes [<xref ref-type="bibr" rid="B51">51</xref>]. Plasmatocytes, which are capable of phagocytosis, are comparable to the monocyte/macrophage lineage of vertebrates. They possess a single ancestor for the VEGF (Vascular Endothelial Growth Factor) and PDGF (Platelet-derived Growth Factor) receptors found in vertebrates. This receptor, called PVR, directs immune cell migration [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. The VEGF-PDGF-system is indispensable for the development of vessels in vertebrates (ECs, pericytes, smooth muscle cells), and it is tempting to speculate that vascular wall cells are derived from macrophage-like cells during phylogeny, and some LECs still do so during ontogeny.</p></sec><sec><title>Pathological lymphangiogenesis</title><p>Lymphangiogenesis in embryos and adult organisms have many mechanisms in common, but they may also differ to some extent. Lymphangiogenesis in the adult takes place in the proliferation phase of the endometrium [<xref ref-type="bibr" rid="B53">53</xref>]. Pathological lymphangiogenesis can be observed in inflammatory diseases such as Crohn's disease and ulcerative colitis [<xref ref-type="bibr" rid="B54">54</xref>], in and around tumours that express the lymphangiogenic growth factors VEGF-C and -D [<xref ref-type="bibr" rid="B55">55</xref>-<xref ref-type="bibr" rid="B57">57</xref>], and during wound healing, where it occurs after blood vessels have formed [<xref ref-type="bibr" rid="B58">58</xref>]. In these scenarios, new lymphatics are mostly formed from pre-existing ones, however, exceptions have been observed. One of these exceptions is the healing of dermal wounds in the mouse tail [<xref ref-type="bibr" rid="B59">59</xref>]. In this model, LECs do not sprout from lymph vessels, but migrate as single cells from distal to proximal parts of the tail and organize into vessels in the direction of interstitial fluid flow. It is tempting to speculate that the dermis of adult organisms still contains lymphendothelial precursor cells, which is in line with our observation of lymphangioblasts in the early dermatomes of murine and avian embryos [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B19">19</xref>].</p><p>Macrophages may support pathological lymphangiogenesis in two ways: either by transdifferentiation and direct incorporation into the endothelial layer or by stimulating division of pre-existing local LECs [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B60">60</xref>]. Thereby, VEGF-C seems to have a dual role as inducer of LEC proliferation and chemoattractant of macrophages [<xref ref-type="bibr" rid="B61">61</xref>]. In diabetes, wound healing is impaired, due to decreased numbers of macrophages (F4/80<sup>+</sup>, Lyve-1<sup>+</sup>, podoplanin<sup>+</sup>) and lymph vessels [<xref ref-type="bibr" rid="B62">62</xref>]. A pool of macrophages expressing VEGFR-3, CD45 and CD11b has been found in the conjunctiva of normal and inflamed murine eyes [<xref ref-type="bibr" rid="B63">63</xref>]. However, further studies are needed to clarify whether their incorporation into lymph vessels is permanent or represents some kind of lymphendothelial mimicry [<xref ref-type="bibr" rid="B24">24</xref>].</p><p>Evidence for circulating cells with lymphendothelial characteristics has been found in human diseases. In patients with gender-mismatched renal transplants and inflammation-associated transplant rejection, Kerjaschki et al. [<xref ref-type="bibr" rid="B25">25</xref>] observed lymphangiogenesis with Ki-67 labelling rates of 2.3% of LECs, and incorporation of circulating recipient-derived cells into kidney lymph vessels in the range of 2.7 &#x02013; 7%. The Ki-67 labelling rates are clearly lower than those we observed in embryonic LECs (in the mouse), whereas the incorporation of circulating progenitor cells into the lining of lymph vessels appears to be relatively high in the adult human. The second disease, which shows involvement of circulating lymphatic progenitor cells, is Kaposi's sarcoma (KS). The cell of origin in KS has long been a subject of debate. Mesenchymal cells, smooth muscle cells, BECs, LECs, Schwann cells and fibroblasts have been discussed. An endothelial origin has then been favoured, but it has remained unclear whether these are BECs or LECs [<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref>]. Studies on the expression of lymphendothelial markers VEGFR-3, podoplanin and Lyve-1, and studies showing the mitogenic effect of VEGF-C seem to prove that KS is derived from LECs [<xref ref-type="bibr" rid="B5">5</xref>]. However, examination of biopsies from KS skin lesions, which developed after transplantation in immuno-suppressed recipients of kidneys, showed that a high proportion of KS cells were of donor (kidney) origin [<xref ref-type="bibr" rid="B6">6</xref>]. These findings suggest that KS cells are derived from highly mobile cells. It is probable that these are macrophage-like, which originated in the donor organ. Cells with macrophage and endothelial characteristics have been isolated from peripheral blood of KS patients [<xref ref-type="bibr" rid="B66">66</xref>].</p></sec></sec><sec><title>Conclusion</title><p>In summary, we describe mesenchymal cells with macrophage and lymphendothelial characteristics in murine embryos. These cells seem to participate in normal lymphangiogenesis and might represent a relict of the phylogenetic development of lymph vessels from immune cells. Similar cells may take part in pathological lymphangiogenesis in the mouse and in human beings, and may be the cell of origin in Kaposi's sarcoma.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>NMRI and C57BL/6 wild type mouse embryos from ED 10 to 13.5 were studied. Embryos were removed from the uterus and remained either unfixed, or were fixed in 4% paraformaldehyde (PFA), or in 100% ethanol containing 3% acetic acid. We did not observe any differences between the two strains.</p></sec><sec><title>Immunohistochemistry</title><p>Mouse embryos were embedded in paraffin and sectioned into 8 &#x003bc;m slices with a microtome (Leica, Bensheim, Germany) and placed onto slides. Sections were stained with rabbit-anti-mouse Lyve-1 antibodies (Regeneron, Tarrytown, NY). The secondary antibody was peroxidase-conjugated goat-anti-rabbit IgG (Sigma-Aldrich, Taufkirchen, Germany). Diaminobenzidine was used as chromogen. Sections were counter stained with nuclear fast red.</p></sec><sec><title>Proliferation studies</title><p>Paraffin sections were stained with rabbit-anti-mouse Lyve-1 antibodies [<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B68">68</xref>] and Ki-67 (Dako, Hamburg, Germany). The Ki-67-antigen was used with citrate buffer in the microwave oven for antigen retrieval. The secondary antibodies, Alexa 488-conjugated goat-anti-rat IgG, and Alexa 594-conjugated goat-anti-rabbit IgG (Molecular Probes, Eugene, US), were applied at a dilution of 1:200, for 1 hour (h). Sections were counter-stained with DAPI.</p></sec><sec><title>Immunofluorescence</title><p>Embryos of various developmental stages remained unfixed or were fixed in 4% PFA for 20 minutes. They were rinsed in phosphate-buffered saline (PBS), transferred to 5% and 15% sucrose in PBS, and embedded in Tissue Freeze Medium (Sakura Finetek Europe, NL). Cryosections of 20 &#x003bc;m thickness were prepared. Non-specific binding of antibodies was blocked by incubation with 1% bovine serum albumin (BSA) for 1 h before incubation with the primary antisera. The following primary antibodies were used in this study for double and triple staining: rabbit-anti-mouse LYVE-1 (Regeneron, Tarrytown, NY), rat-anti-mouse CD31/PECAM-1 (1:50; BD Pharmingen, San Diego, US), rabbit-anti-human Prox1 (1:750; ReliaTech, Braunschweig, Germany), rat-anti-mouse Ki-67 (1:50; Dako, Hamburg, Germany), rat-anti-mouse CD11b (1:50; BD Pharmingen, San Diego, US), rat-anti-mouse F4/80 (1:100; Hycult Biotechnology, Uden, Netherlands), and rat-anti-mouse LA102 (pure supernatant, T. Ezaki, Japan). The sections were incubated with the primary antibodies for 1 h, except for Prox1, which was incubated overnight. In the negative controls, the primary antibody was omitted. Typical controls have been published [<xref ref-type="bibr" rid="B19">19</xref>]. After having been rinsed, the secondary Alexa 488-conjugated goat-anti-rat IgG and Alexa 594-conjugated goat-anti-rabbit IgG (Molecular Probes, Eugene, US) were applied at a dilution of 1:200. Alexa 350-conjugated goat-anti-rabbit IgG (Molecular Probes) was applied at 1:50 for 1 h. After having been rinsed, the sections were mounted under cover slips with Fluoromount-G (Southern Biotechnology Associates, Birmingham, GB). They were then viewed with the DM5000B epifluorescence microscope (Leica, Bensheim, Germany) and Zeiss Axioplan 2 LSM 510 (Zeiss, G&#x000f6;ttingen, Germany).</p></sec></sec><sec><title>Authors' contributions</title><p>KB carried out immunostaining and was involved in the analysis of data and preparation of the manuscript. TE performed immunostaining with lymphendothelial marker LA102. JW conceived the study and participated in its design, data analysis and manuscript preparation.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Mrs. C. Maelicke for copy-editing the manuscript. This study was supported by a grant (Wi 1452/11-1) from the Deutsche Forschungsgemeinschaft.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>MH</given-names></name><name><surname>Bernas</surname><given-names>MJ</given-names></name><name><surname>Martin</surname><given-names>CP</given-names></name><name><surname>Witte</surname><given-names>CL</given-names></name></person-group><article-title>Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology</article-title><source>Microsc Res Tech</source><year>2001</year><volume>55</volume><fpage>122</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">11596157</pub-id><pub-id pub-id-type="doi">10.1002/jemt.1163</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Hawighorst</surname><given-names>T</given-names></name><name><surname>Hecht</surname><given-names>M</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name></person-group><article-title>Development of lymphatic vessels: tumour lymphangiogenesis and lymphatic invasion</article-title><source>Curr Med Chem</source><year>2005</year><volume>12</volume><fpage>3043</fpage><lpage>3053</lpage><pub-id pub-id-type="pmid">16375699</pub-id><pub-id pub-id-type="doi">10.2174/092986705774933407</pub-id></citation></ref><ref id="B3"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Karkkainen</surname><given-names>MJ</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Lawrence</surname><given-names>EC</given-names></name><name><surname>Kimak</surname><given-names>MA</given-names></name><name><surname>Levinson</surname><given-names>KL</given-names></name><name><surname>McTigue</surname><given-names>MA</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Finegold</surname><given-names>DN</given-names></name></person-group><article-title>Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><edition>2000/06/03</edition><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">10835628</pub-id><pub-id pub-id-type="doi">10.1038/75997</pub-id></citation></ref><ref id="B4"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Irrthum</surname><given-names>A</given-names></name><name><surname>Karkkainen</surname><given-names>MJ</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Vikkula</surname><given-names>M</given-names></name></person-group><article-title>Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><edition>2000/06/17</edition><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">10856194</pub-id><pub-id pub-id-type="doi">10.1086/303019</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>L</given-names></name><name><surname>Rockson</surname><given-names>SG</given-names></name></person-group><article-title>The lymphatic biology of Kaposi's sarcoma</article-title><source>Lymphat Res Biol</source><year>2005</year><volume>3</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15770083</pub-id><pub-id pub-id-type="doi">10.1089/lrb.2005.3.25</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barozzi</surname><given-names>P</given-names></name><name><surname>Luppi</surname><given-names>M</given-names></name><name><surname>Facchetti</surname><given-names>F</given-names></name><name><surname>Mecucci</surname><given-names>C</given-names></name><name><surname>Alu</surname><given-names>M</given-names></name><name><surname>Sarid</surname><given-names>R</given-names></name><name><surname>Rasini</surname><given-names>V</given-names></name><name><surname>Ravazzini</surname><given-names>L</given-names></name><name><surname>Rossi</surname><given-names>E</given-names></name><name><surname>Festa</surname><given-names>S</given-names></name><name><surname>Crescenzi</surname><given-names>B</given-names></name><name><surname>Wolf</surname><given-names>DG</given-names></name><name><surname>Schulz</surname><given-names>TF</given-names></name><name><surname>Torelli</surname><given-names>G</given-names></name></person-group><article-title>Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors</article-title><source>Nat Med</source><year>2003</year><volume>9</volume><fpage>554</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">12692543</pub-id><pub-id pub-id-type="doi">10.1038/nm862</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filston</surname><given-names>HC</given-names></name></person-group><article-title>Hemangiomas, cystic hygromas, and teratomas of the head and neck</article-title><source>Semin Pediatr Surg</source><year>1994</year><volume>3</volume><fpage>147</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">7987630</pub-id></citation></ref><ref id="B8"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Nobuhara</surname><given-names>Y</given-names></name><name><surname>Onoda</surname><given-names>N</given-names></name><name><surname>Fukai</surname><given-names>K</given-names></name><name><surname>Hosomi</surname><given-names>N</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Wakasa</surname><given-names>K</given-names></name><name><surname>Nishihara</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Hirakawa</surname><given-names>K</given-names></name></person-group><article-title>TIE2 gain-of-function mutation in a patient with pancreatic lymphangioma associated with blue rubber-bleb nevus syndrome: report of a case</article-title><source>Surg Today</source><year>2006</year><volume>36</volume><edition>2006/02/24</edition><fpage>283</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">16493543</pub-id><pub-id pub-id-type="doi">10.1007/s00595-005-3138-9</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeltsch</surname><given-names>M</given-names></name><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name></person-group><article-title>Genesis and pathogenesis of lymphatic vessels</article-title><source>Cell Tissue Res</source><year>2003</year><volume>314</volume><fpage>69</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">12942362</pub-id><pub-id pub-id-type="doi">10.1007/s00441-003-0777-2</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Petrova</surname><given-names>TV</given-names></name></person-group><article-title>Lymphangiogenesis in development and human disease</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>946</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">16355212</pub-id><pub-id pub-id-type="doi">10.1038/nature04480</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>FR</given-names></name></person-group><article-title>On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig</article-title><source>Amer J Anat</source><year>1902</year><volume>1</volume><fpage>367</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1002/aja.1000010310</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>FR</given-names></name></person-group><article-title>The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole</article-title><source>Amer J Anat</source><year>1909</year><volume>9</volume><fpage>43</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/aja.1000090104</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>F</given-names></name></person-group><article-title>The development of the lymphatic system in Rabbits</article-title><source>Amer J Anat</source><year>1905</year><volume>5</volume><fpage>95</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/aja.1000050107</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huntington</surname><given-names>GS</given-names></name><name><surname>Mc Clure</surname><given-names>CFW</given-names></name></person-group><article-title>The anatomy and development of the jugular lymph sacs in the domestic cat (Felis domestica)</article-title><source>Am J Anat</source><year>1910</year><volume>10</volume><fpage>177</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1002/aja.1000100108</pub-id></citation></ref><ref id="B15"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>RS</given-names></name><name><surname>Dillard</surname><given-names>ME</given-names></name><name><surname>Lagutin</surname><given-names>OV</given-names></name><name><surname>Lin</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Samokhvalov</surname><given-names>IM</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name></person-group><article-title>Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature</article-title><source>Genes Dev</source><year>2007</year><volume>21</volume><edition>2007/10/03</edition><fpage>2422</fpage><lpage>2432</lpage><pub-id pub-id-type="pmid">17908929</pub-id><pub-id pub-id-type="doi">10.1101/gad.1588407</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wigle</surname><given-names>JT</given-names></name><name><surname>Harvey</surname><given-names>N</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name><name><surname>Lagutina</surname><given-names>I</given-names></name><name><surname>Grosveld</surname><given-names>G</given-names></name><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name></person-group><article-title>An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype</article-title><source>Embo J</source><year>2002</year><volume>21</volume><fpage>1505</fpage><lpage>1513</lpage><pub-id pub-id-type="pmid">11927535</pub-id><pub-id pub-id-type="doi">10.1093/emboj/21.7.1505</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wigle</surname><given-names>JT</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name></person-group><article-title>Prox1 function is required for the development of the murine lymphatic system</article-title><source>Cell</source><year>1999</year><volume>98</volume><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">10499794</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81511-1</pub-id></citation></ref><ref id="B18"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Ny</surname><given-names>A</given-names></name><name><surname>Autiero</surname><given-names>M</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><article-title>Zebrafish and Xenopus tadpoles: small animal models to study angiogenesis and lymphangiogenesis</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><edition>2005/11/29</edition><fpage>684</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">16309670</pub-id><pub-id pub-id-type="doi">10.1016/j.yexcr.2005.10.018</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buttler</surname><given-names>K</given-names></name><name><surname>Kreysing</surname><given-names>A</given-names></name><name><surname>von Kaisenberg</surname><given-names>CS</given-names></name><name><surname>Schweigerer</surname><given-names>L</given-names></name><name><surname>Gale</surname><given-names>N</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name></person-group><article-title>Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos</article-title><source>Dev Dyn</source><year>2006</year><volume>235</volume><fpage>1554</fpage><lpage>1562</lpage><pub-id pub-id-type="pmid">16502417</pub-id><pub-id pub-id-type="doi">10.1002/dvdy.20737</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Aref</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Tomarev</surname><given-names>SI</given-names></name><name><surname>Schweigerer</surname><given-names>L</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Valasek</surname><given-names>P</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name></person-group><article-title>Dual origin of avian lymphatics</article-title><source>Dev Biol</source><year>2006</year><volume>292</volume><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">16457798</pub-id><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.12.043</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaniv</surname><given-names>K</given-names></name><name><surname>Isogai</surname><given-names>S</given-names></name><name><surname>Castranova</surname><given-names>D</given-names></name><name><surname>Dye</surname><given-names>L</given-names></name><name><surname>Hitomi</surname><given-names>J</given-names></name><name><surname>Weinstein</surname><given-names>BM</given-names></name></person-group><article-title>Live imaging of lymphatic development in the zebrafish</article-title><source>Nat Med</source><year>2006</year><volume>12</volume><fpage>711</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">16732279</pub-id><pub-id pub-id-type="doi">10.1038/nm1427</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Ii</surname><given-names>M</given-names></name><name><surname>Cursiefen</surname><given-names>C</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Keino</surname><given-names>H</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Takenaka</surname><given-names>H</given-names></name><name><surname>D'Amore</surname><given-names>PA</given-names></name><name><surname>Stein-Streilein</surname><given-names>J</given-names></name><name><surname>Losordo</surname><given-names>DW</given-names></name><name><surname>Streilein</surname><given-names>JW</given-names></name></person-group><article-title>Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>2363</fpage><lpage>2372</lpage><pub-id pub-id-type="pmid">16138190</pub-id><pub-id pub-id-type="doi">10.1172/JCI23874</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Religa</surname><given-names>P</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Bjorndahl</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>4184</fpage><lpage>4190</lpage><pub-id pub-id-type="pmid">16141354</pub-id><pub-id pub-id-type="doi">10.1182/blood-2005-01-0226</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schledzewski</surname><given-names>K</given-names></name><name><surname>Falkowski</surname><given-names>M</given-names></name><name><surname>Moldenhauer</surname><given-names>G</given-names></name><name><surname>Metharom</surname><given-names>P</given-names></name><name><surname>Kzhyshkowska</surname><given-names>J</given-names></name><name><surname>Ganss</surname><given-names>R</given-names></name><name><surname>Demory</surname><given-names>A</given-names></name><name><surname>Falkowska-Hansen</surname><given-names>B</given-names></name><name><surname>Kurzen</surname><given-names>H</given-names></name><name><surname>Ugurel</surname><given-names>S</given-names></name><name><surname>Geginat</surname><given-names>G</given-names></name><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>Goerdt</surname><given-names>S</given-names></name></person-group><article-title>Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis</article-title><source>J Pathol</source><year>2006</year><volume>209</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">16482496</pub-id><pub-id pub-id-type="doi">10.1002/path.1942</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Huttary</surname><given-names>N</given-names></name><name><surname>Raab</surname><given-names>I</given-names></name><name><surname>Regele</surname><given-names>H</given-names></name><name><surname>Bojarski-Nagy</surname><given-names>K</given-names></name><name><surname>Bartel</surname><given-names>G</given-names></name><name><surname>Krober</surname><given-names>SM</given-names></name><name><surname>Greinix</surname><given-names>H</given-names></name><name><surname>Rosenmaier</surname><given-names>A</given-names></name><name><surname>Karlhofer</surname><given-names>F</given-names></name><name><surname>Wick</surname><given-names>N</given-names></name><name><surname>Mazal</surname><given-names>PR</given-names></name></person-group><article-title>Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants</article-title><source>Nat Med</source><year>2006</year><volume>12</volume><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16415878</pub-id><pub-id pub-id-type="doi">10.1038/nm1340</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ezaki</surname><given-names>T</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Morikawa</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Sakaguchi</surname><given-names>N</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name><name><surname>Matsuno</surname><given-names>K</given-names></name></person-group><article-title>Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells</article-title><source>Anat Embryol (Berl)</source><year>2006</year><volume>211</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">16685512</pub-id><pub-id pub-id-type="doi">10.1007/s00429-006-0091-3</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>RC</given-names></name></person-group><article-title>Characteristics of lymphatic endothelial cells in physiological and pathological conditions</article-title><source>Histol Histopathol</source><year>2005</year><volume>20</volume><fpage>155</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">15578435</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>RC</given-names></name></person-group><article-title>Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players</article-title><source>Curr Med Chem</source><year>2007</year><volume>14</volume><fpage>2359</fpage><lpage>2368</lpage><pub-id pub-id-type="pmid">17896984</pub-id><pub-id pub-id-type="doi">10.2174/092986707781745541</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norgall</surname><given-names>S</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name><name><surname>R&#x000f6;ssler</surname><given-names>J</given-names></name><name><surname>Schweigerer</surname><given-names>L</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Weich</surname><given-names>HA</given-names></name></person-group><article-title>Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas</article-title><source>BMC Cancer</source><year>2007</year><comment></comment><pub-id pub-id-type="pmid">17584927</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name><name><surname>von Kaisenberg</surname><given-names>CS</given-names></name><name><surname>Borges</surname><given-names>J</given-names></name><name><surname>Stark</surname><given-names>GB</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Tomarev</surname><given-names>SI</given-names></name><name><surname>Niemeyer</surname><given-names>C</given-names></name><name><surname>Rossler</surname><given-names>J</given-names></name></person-group><article-title>The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues</article-title><source>Faseb J</source><year>2002</year><volume>16</volume><fpage>1271</fpage><lpage>1273</lpage><pub-id pub-id-type="pmid">12060670</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scholzen</surname><given-names>T</given-names></name><name><surname>Gerdes</surname><given-names>J</given-names></name></person-group><article-title>The Ki-67 protein: from the known and the unknown</article-title><source>J Cell Physiol</source><year>2000</year><volume>182</volume><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">10653597</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(200003)182:3&#x0003c;311::AID-JCP1&#x0003e;3.0.CO;2-9</pub-id></citation></ref><ref id="B32"><citation citation-type="book"><person-group person-group-type="author"><name><surname>You</surname><given-names>LR</given-names></name><name><surname>Takamoto</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>CT</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Demayo</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name></person-group><article-title>Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><edition>2005/10/28</edition><fpage>16351</fpage><lpage>16356</lpage><pub-id pub-id-type="pmid">16251273</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0507832102</pub-id></citation></ref><ref id="B33"><citation citation-type="book"><person-group person-group-type="author"><name><surname>You</surname><given-names>LR</given-names></name><name><surname>Lin</surname><given-names>FJ</given-names></name><name><surname>Lee</surname><given-names>CT</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name></person-group><article-title>Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity</article-title><source>Nature</source><year>2005</year><volume>435</volume><edition>2005/05/06</edition><fpage>98</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">15875024</pub-id><pub-id pub-id-type="doi">10.1038/nature03511</pub-id></citation></ref><ref id="B34"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>B</given-names></name><name><surname>Bechara</surname><given-names>EJ</given-names></name><name><surname>Mendonca</surname><given-names>JR</given-names></name><name><surname>Curi</surname><given-names>R</given-names></name></person-group><article-title>Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of rats treated with dexamethasone</article-title><source>Cell Biochem Funct</source><year>1999</year><volume>17</volume><edition>1999/04/07</edition><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">10191504</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1099-0844(199903)17:1&#x0003c;15::AID-CBF804&#x0003e;3.0.CO;2-T</pub-id></citation></ref><ref id="B35"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RL</given-names></name><name><surname>Ibrahim</surname><given-names>T</given-names></name><name><surname>Lucchetti</surname><given-names>L</given-names></name><name><surname>da Silva</surname><given-names>AJ</given-names></name><name><surname>Goncalves de Moraes</surname><given-names>VL</given-names></name></person-group><article-title>Immunosuppressive and anti-inflammatory effects of methanolic extract and the polyacetylene isolated from Bidens pilosa L</article-title><source>Immunopharmacology</source><year>1999</year><volume>43</volume><edition>1999/08/07</edition><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">10437654</pub-id><pub-id pub-id-type="doi">10.1016/S0162-3109(99)00039-9</pub-id></citation></ref><ref id="B36"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>FA</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name></person-group><article-title>The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><edition>1999/04/24</edition><fpage>1037</fpage><lpage>1049</lpage><pub-id pub-id-type="pmid">10215630</pub-id><pub-id pub-id-type="doi">10.1101/gad.13.8.1037</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>T</given-names></name><name><surname>van Deursen</surname><given-names>J</given-names></name><name><surname>Hiebert</surname><given-names>SW</given-names></name><name><surname>Grosveld</surname><given-names>G</given-names></name><name><surname>Downing</surname><given-names>JR</given-names></name></person-group><article-title>AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis</article-title><source>Cell</source><year>1996</year><volume>84</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">8565077</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80986-1</pub-id></citation></ref><ref id="B38"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Obergfell</surname><given-names>A</given-names></name><name><surname>Judd</surname><given-names>BA</given-names></name><name><surname>del Pozo</surname><given-names>MA</given-names></name><name><surname>Schwartz</surname><given-names>MA</given-names></name><name><surname>Koretzky</surname><given-names>GA</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name></person-group><article-title>The molecular adapter SLP-76 relays signals from platelet integrin alphaIIbbeta3 to the actin cytoskeleton</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><edition>2000/12/13</edition><fpage>5916</fpage><lpage>5923</lpage><pub-id pub-id-type="pmid">11113155</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M010639200</pub-id></citation></ref><ref id="B39"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Mocsai</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Tybulewicz</surname><given-names>VL</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><article-title>Syk is required for integrin signaling in neutrophils</article-title><source>Immunity</source><year>2002</year><volume>16</volume><edition>2002/04/24</edition><fpage>547</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">11970878</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00303-5</pub-id></citation></ref><ref id="B40"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sebzda</surname><given-names>E</given-names></name><name><surname>Hibbard</surname><given-names>C</given-names></name><name><surname>Sweeney</surname><given-names>S</given-names></name><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Bezman</surname><given-names>N</given-names></name><name><surname>Clemens</surname><given-names>G</given-names></name><name><surname>Maltzman</surname><given-names>JS</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Tybulewicz</surname><given-names>V</given-names></name><name><surname>Koretzky</surname><given-names>GA</given-names></name><name><surname>Kahn</surname><given-names>ML</given-names></name></person-group><article-title>Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development</article-title><source>Dev Cell</source><year>2006</year><volume>11</volume><edition>2006/09/05</edition><fpage>349</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">16950126</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2006.07.007</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Guerriero</surname><given-names>A</given-names></name><name><surname>Sebzda</surname><given-names>E</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Mocsai</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>EE</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Ferrari</surname><given-names>VA</given-names></name><name><surname>Tybulewicz</surname><given-names>V</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name><name><surname>Lepore</surname><given-names>JJ</given-names></name><name><surname>Koretzky</surname><given-names>GA</given-names></name><name><surname>Kahn</surname><given-names>ML</given-names></name></person-group><article-title>Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">12522250</pub-id><pub-id pub-id-type="doi">10.1126/science.1079477</pub-id></citation></ref><ref id="B42"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>NC</given-names></name><name><surname>Worku</surname><given-names>M</given-names></name><name><surname>Paape</surname><given-names>MJ</given-names></name><name><surname>Grier</surname><given-names>P</given-names></name><name><surname>Rexroad</surname><given-names>CE</given-names><suffix>Jr.</suffix></name><name><surname>Pursel</surname><given-names>VG</given-names></name></person-group><article-title>Continuous cultures of macrophages derived from the 8-day epiblast of the pig</article-title><source>In Vitro Cell Dev Biol Anim</source><year>1996</year><volume>32</volume><edition>1996/10/01</edition><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">8946226</pub-id><pub-id pub-id-type="doi">10.1007/BF02722981</pub-id></citation></ref><ref id="B43"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>H</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name></person-group><article-title>Embryonic CNS macrophages and microglia do not stem from circulating, but from extravascular precursors</article-title><source>Glia</source><year>1998</year><volume>22</volume><edition>1998/01/22</edition><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">9436792</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(199801)22:1&#x0003c;98::AID-GLIA10&#x0003e;3.0.CO;2-V</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malorny</surname><given-names>U</given-names></name><name><surname>Michels</surname><given-names>E</given-names></name><name><surname>Sorg</surname><given-names>C</given-names></name></person-group><article-title>A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes</article-title><source>Cell Tissue Res</source><year>1986</year><volume>243</volume><fpage>421</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">3948241</pub-id><pub-id pub-id-type="doi">10.1007/BF00251059</pub-id></citation></ref><ref id="B45"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Flotte</surname><given-names>TJ</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Thorbecke</surname><given-names>GJ</given-names></name></person-group><article-title>Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets</article-title><source>Am J Pathol</source><year>1983</year><volume>111</volume><edition>1983/04/01</edition><fpage>112</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">6340516</pub-id></citation></ref><ref id="B46"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Popichenko</surname><given-names>D</given-names></name><name><surname>Paululat</surname><given-names>A</given-names></name></person-group><article-title>Cell fate decisions in the Drosophila dorsal vessel depend on the multiadapter protein inscuteable</article-title><source>Genesis</source><year>2004</year><volume>40</volume><edition>2004/12/14</edition><fpage>218</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">15593331</pub-id><pub-id pub-id-type="doi">10.1002/gene.20080</pub-id></citation></ref><ref id="B47"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Duchek</surname><given-names>P</given-names></name><name><surname>Rorth</surname><given-names>P</given-names></name></person-group><article-title>Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis</article-title><source>Science</source><year>2001</year><volume>291</volume><edition>2001/01/06</edition><fpage>131</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">11141565</pub-id><pub-id pub-id-type="doi">10.1126/science.291.5501.131</pub-id></citation></ref><ref id="B48"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Duchek</surname><given-names>P</given-names></name><name><surname>Somogyi</surname><given-names>K</given-names></name><name><surname>Jekely</surname><given-names>G</given-names></name><name><surname>Beccari</surname><given-names>S</given-names></name><name><surname>Rorth</surname><given-names>P</given-names></name></person-group><article-title>Guidance of cell migration by the Drosophila PDGF/VEGF receptor</article-title><source>Cell</source><year>2001</year><volume>107</volume><edition>2001/10/12</edition><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11595182</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00502-5</pub-id></citation></ref><ref id="B49"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Heino</surname><given-names>TI</given-names></name><name><surname>Karpanen</surname><given-names>T</given-names></name><name><surname>Wahlstrom</surname><given-names>G</given-names></name><name><surname>Pulkkinen</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>U</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Roos</surname><given-names>C</given-names></name></person-group><article-title>The Drosophila VEGF receptor homolog is expressed in hemocytes</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><edition>2001/10/26</edition><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">11677054</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00510-X</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Papoutsi</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>J</given-names></name></person-group><article-title>The lymphatic vascular system: secondary or primary?</article-title><source>Lymphology</source><year>2004</year><volume>37</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">15560105</pub-id></citation></ref><ref id="B51"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Meister</surname><given-names>M</given-names></name><name><surname>Lagueux</surname><given-names>M</given-names></name></person-group><article-title>Drosophila blood cells</article-title><source>Cell Microbiol</source><year>2003</year><volume>5</volume><edition>2003/08/20</edition><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">12925127</pub-id><pub-id pub-id-type="doi">10.1046/j.1462-5822.2003.00302.x</pub-id></citation></ref><ref id="B52"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>NK</given-names></name><name><surname>Keyes</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Heller</surname><given-names>J</given-names></name><name><surname>Ryner</surname><given-names>L</given-names></name><name><surname>Karim</surname><given-names>F</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name></person-group><article-title>Developmental control of blood cell migration by the Drosophila VEGF pathway</article-title><source>Cell</source><year>2002</year><volume>108</volume><edition>2002/04/17</edition><fpage>865</fpage><lpage>876</lpage><pub-id pub-id-type="pmid">11955438</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00676-1</pub-id></citation></ref><ref id="B53"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Donoghue</surname><given-names>JF</given-names></name><name><surname>Lederman</surname><given-names>FL</given-names></name><name><surname>Susil</surname><given-names>BJ</given-names></name><name><surname>Rogers</surname><given-names>PA</given-names></name></person-group><article-title>Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma</article-title><source>Hum Reprod</source><year>2007</year><volume>22</volume><edition>2007/03/10</edition><fpage>1705</fpage><lpage>1713</lpage><pub-id pub-id-type="pmid">17347164</pub-id><pub-id pub-id-type="doi">10.1093/humrep/dem037</pub-id></citation></ref><ref id="B54"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Geleff</surname><given-names>S</given-names></name><name><surname>Schoppmann</surname><given-names>SF</given-names></name><name><surname>Oberhuber</surname><given-names>G</given-names></name></person-group><article-title>Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease</article-title><source>Virchows Arch</source><year>2003</year><volume>442</volume><edition>2003/03/21</edition><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">12647212</pub-id></citation></ref><ref id="B55"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Skobe</surname><given-names>M</given-names></name><name><surname>Hawighorst</surname><given-names>T</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Prevo</surname><given-names>R</given-names></name><name><surname>Janes</surname><given-names>L</given-names></name><name><surname>Velasco</surname><given-names>P</given-names></name><name><surname>Riccardi</surname><given-names>L</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Claffey</surname><given-names>K</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name></person-group><article-title>Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><edition>2001/02/15</edition><fpage>192</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">11175850</pub-id><pub-id pub-id-type="doi">10.1038/84643</pub-id></citation></ref><ref id="B56"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Stacker</surname><given-names>SA</given-names></name><name><surname>Caesar</surname><given-names>C</given-names></name><name><surname>Baldwin</surname><given-names>ME</given-names></name><name><surname>Thornton</surname><given-names>GE</given-names></name><name><surname>Williams</surname><given-names>RA</given-names></name><name><surname>Prevo</surname><given-names>R</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Kubo</surname><given-names>H</given-names></name><name><surname>Achen</surname><given-names>MG</given-names></name></person-group><article-title>VEGF-D promotes the metastatic spread of tumor cells via the lymphatics</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><edition>2001/02/15</edition><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">11175849</pub-id><pub-id pub-id-type="doi">10.1038/84635</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papoutsi</surname><given-names>M</given-names></name><name><surname>Siemeister</surname><given-names>G</given-names></name><name><surname>Weindel</surname><given-names>K</given-names></name><name><surname>Tomarev</surname><given-names>SI</given-names></name><name><surname>Kurz</surname><given-names>H</given-names></name><name><surname>Schachtele</surname><given-names>C</given-names></name><name><surname>Martiny-Baron</surname><given-names>G</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Marme</surname><given-names>D</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name></person-group><article-title>Active interaction of human A375 melanoma cells with the lymphatics in vivo</article-title><source>Histochem Cell Biol</source><year>2000</year><volume>114</volume><fpage>373</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">11151407</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pepper</surname><given-names>MS</given-names></name><name><surname>Skobe</surname><given-names>M</given-names></name></person-group><article-title>Lymphatic endothelium: morphological, molecular and functional properties</article-title><source>J Cell Biol</source><year>2003</year><volume>163</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">14581448</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200308082</pub-id></citation></ref><ref id="B59"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Rutkowski</surname><given-names>JM</given-names></name><name><surname>Boardman</surname><given-names>KC</given-names></name><name><surname>Swartz</surname><given-names>MA</given-names></name></person-group><article-title>Characterization of lymphangiogenesis in a model of adult skin regeneration</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2006</year></citation></ref><ref id="B60"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schoppmann</surname><given-names>SF</given-names></name><name><surname>Birner</surname><given-names>P</given-names></name><name><surname>Stockl</surname><given-names>J</given-names></name><name><surname>Kalt</surname><given-names>R</given-names></name><name><surname>Ullrich</surname><given-names>R</given-names></name><name><surname>Caucig</surname><given-names>C</given-names></name><name><surname>Kriehuber</surname><given-names>E</given-names></name><name><surname>Nagy</surname><given-names>K</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Kerjaschki</surname><given-names>D</given-names></name></person-group><article-title>Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis</article-title><source>Am J Pathol</source><year>2002</year><volume>161</volume><edition>2002/09/06</edition><fpage>947</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">12213723</pub-id></citation></ref><ref id="B61"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Skobe</surname><given-names>M</given-names></name><name><surname>Hamberg</surname><given-names>LM</given-names></name><name><surname>Hawighorst</surname><given-names>T</given-names></name><name><surname>Schirner</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>GL</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name></person-group><article-title>Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma</article-title><source>Am J Pathol</source><year>2001</year><volume>159</volume><edition>2001/09/11</edition><fpage>893</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">11549582</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Asai</surname><given-names>J</given-names></name><name><surname>Ii</surname><given-names>M</given-names></name><name><surname>Thorne</surname><given-names>T</given-names></name><name><surname>Losordo</surname><given-names>DW</given-names></name><name><surname>D'Amore</surname><given-names>PA</given-names></name></person-group><article-title>Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing</article-title><source>Am J Pathol</source><year>2007</year><volume>170</volume><fpage>1178</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">17392158</pub-id><pub-id pub-id-type="doi">10.2353/ajpath.2007.060018</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamrah</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Cursiefen</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Joyce</surname><given-names>NC</given-names></name><name><surname>Dana</surname><given-names>MR</given-names></name></person-group><article-title>Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva</article-title><source>Experimental Eye Research</source><year>2004</year><volume>79</volume><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">15381039</pub-id><pub-id pub-id-type="doi">10.1016/j.exer.2004.06.028</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dictor</surname><given-names>M</given-names></name></person-group><article-title>Kaposi's sarcoma. Origin and significance of lymphaticovenous connections</article-title><source>Virchows Arch A Pathol Anat Histopathol</source><year>1986</year><volume>409</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">3085337</pub-id><pub-id pub-id-type="doi">10.1007/BF00705404</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutgers</surname><given-names>JL</given-names></name><name><surname>Wieczorek</surname><given-names>R</given-names></name><name><surname>Bonetti</surname><given-names>F</given-names></name><name><surname>Kaplan</surname><given-names>KL</given-names></name><name><surname>Posnett</surname><given-names>DN</given-names></name><name><surname>Friedman-Kien</surname><given-names>AE</given-names></name><name><surname>Knowles</surname><given-names>DM</given-names><suffix>2nd</suffix></name></person-group><article-title>The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin</article-title><source>Am J Pathol</source><year>1986</year><volume>122</volume><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">3953772</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uccini</surname><given-names>S</given-names></name><name><surname>Sirianni</surname><given-names>MC</given-names></name><name><surname>Vincenzi</surname><given-names>L</given-names></name><name><surname>Topino</surname><given-names>S</given-names></name><name><surname>Stoppacciaro</surname><given-names>A</given-names></name><name><surname>Lesnoni La Parola</surname><given-names>I</given-names></name><name><surname>Capuano</surname><given-names>M</given-names></name><name><surname>Masini</surname><given-names>C</given-names></name><name><surname>Cerimele</surname><given-names>D</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Baroni</surname><given-names>CD</given-names></name><name><surname>Ruco</surname><given-names>LP</given-names></name></person-group><article-title>Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients</article-title><source>Am J Pathol</source><year>1997</year><volume>150</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">9060831</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerji</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>SX</given-names></name><name><surname>Clasper</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Tammi</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name></person-group><article-title>LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan</article-title><source>J Cell Biol</source><year>1999</year><volume>144</volume><fpage>789</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">10037799</pub-id><pub-id pub-id-type="doi">10.1083/jcb.144.4.789</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prevo</surname><given-names>R</given-names></name><name><surname>Banerji</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>DJ</given-names></name><name><surname>Clasper</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name></person-group><article-title>Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>19420</fpage><lpage>19430</lpage><pub-id pub-id-type="pmid">11278811</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M011004200</pub-id></citation></ref></ref-list></back></article> 